| Line item | 2025-12-31 FY | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | $1.19M | -$3.88M | $96.00K | -$4.02M | -$35.25M | $35.98M |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – |